Resource Centers
- FDA Approves Romidepsin for Refractory Cutaneous T-Cell Lymphoma
- Gram-Negative Hospital Infections Now Showing Resistance to Polymixin B
- U.S. States, Counties Struggle to Deliver H1N1 Shots
- Limiting Working Hours May Compromise Surgeons' Education and Patient Care
- Alert Cordis Crossover Sheath Introducer Recalled
Business of Medicine Journals
Medscape Community Resources
POLL
The Obama administration recently told federal prosecutors not to pursue patients who use medical marijuana in states where it is legal, unless they are using it for illegal purposes. Do you approve or disapprove of the policy change?
- A Treatment Option for Atrial Fibrillation
- A single medication with 4 indications
- A treatment option for ACS and DVT/PE
- ABILIFY® (aripiprazole)
- ACUVUE® Brand Contact Lenses
- ADHD treatment: Efficacy, insights, and dosing
- ALIMTA® (pemetrexed for injection)
- Argatroban
- Atrial Fibrillation Condition Site
- COSAMIN®DS
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- Clinical Management Center
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- ENABLEX® (darifenacin) Extended-Release Tablets 7.5 mg or 15 mg
- Epilepsy360: Connections in Care
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEMZAR® (gemcitabine HCI)
- GEODON® (ziprasidone HCI)
- Genomic Advances in Cardiovascular Care
- Heartmate II® Left Ventricular Assist System
- IL-6 and Rheumatoid Arthritis
- ISENTRESS® (raltegravir) Tablets
- Institute for Advances in Point-of-Care Testing
- Kidney Transplantation
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NUCYNTA™ (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- Navigenics® Genetic Risk Assessment Services
- Neuroendocrine tumors: Increasing in incidence and easy to overlook
- Neutrogena® Pure & Free™ Baby Sunblock Lotion
- OPTIMAL Forum™
- Onglyza™ (saxagliptin) InfoSite
- PEGASYS (peginterferon alfa-2a) for injection
- PREMARIN® (conjugated estrogens tablets, USP)
- PRISTIQ® (desvenlafaxine)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- QuickVue® Influenza A+B Test
- REBIF® (interferon beta-1a)
- RITUXAN® (Rituximab)
- Reclast® (zoledronic acid) injection
- Research VEGF: Emerging Research Around Targeting VEGF
- Risk of Osteoporosis
- Survivorship and Early Breast Cancer Information
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- TOVIAZ® (fesoterodine fumarate)
- Talecris Hypermunes™
- Targeted Biologic Therapy in Breast Cancer
- Targeting CD20: Scientific Insights and Implications for Therapy
- The HER signaling network and cancer
- The Pain Institute
- The Science of Facial Aging
- Treatment of Pulmonary Arterial Hypertension
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
- XYZAL® (levocetirizine dihydrochloride)
Advisory Board
- George S. Conomikes, BA, MA
- Jeffrey J. Denning
- Eric S. Fishman, MD
- Gregory A. Hood, MD
- Brian Kern, Esq.
- Kathryn I. Moghadas, RN, CLRM, CHBC, CPC, CHCC
- Joseph E. Scherger, MD, MPH
- Robert C. Scroggins, JD, CPA, CHBC
- Elizabeth Woodcock, MBA
Site Editorial Directors
Site Editor
